India’s Supreme Court to Hear Dispute on Drug Patent.

When china was the world's shop floor, India were taken place as the world pharmacy, and it has been the largest and lifesaving medicines in poor countries across the globe, But most of there medicine has been the name brand drugs, that were protected by the patents in Europe and in the United States. Novartis is the supply chain by forcing the Indian government to recognise a patent for cancer treatment as a breakthrough for people with a deadly form of leukemia. Novartis is a supply of inexpensive medicines to treat AIDS, cancer, and other diseases. The supreme court has been preparing to hear the final arguments in the month. The Indian government has denied the patent for Mr. Gleevec for many other drugs made by the Western drug makers. This case about drugs has been winding through the Indian legal system for six years. The Pacific Rim trade agreed to the Trans-pacific partnership to grant patents in situations similar to involving Gleevec, to the leaked text of the goverments position. This decision could also help determine how much Western drugs companies has been invest in India at a tie when they wanted to increase sales in emerging markets to compensate for business in the United States and in the Western Europe. The United States Food and Drug Administration was approved in 2001 after a rapid review. Gleevc can cost about $70.000 a year in the United States. The company says it has programs through patents in poor countries that an get a hefty discount or in some cases for free. In Indian generic versions cost about $2,500 a year.

My opinion about this article is that making a drug to help prevent people from getting sick and helping treat AIDS, cancer and other diseases, i think they should be making it. The goverment should have the time to take out and think about what they are trying to do to help people out. I think they they are doing is a good thing for them to be doing, cause i would do the same thing.